Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 29, 2022PLoS neglected tropical diseasesOpen Access

Why the mycetoma patients are still neglected

View Full Paper
Ask AI
Bookmark
Share

Authors

AFAhmed Hassan FahalKAKannan O. AhmedASAli Awadallah Saeed

Discussion

Loading...

Member takes

Overview

Policy review reveals persistent deficits in funding and therapeutic pipelines for mycetoma worldwide, highlighting severe ongoing neglect within global neglected tropical disease agendas.

Key Points

  • To examine why mycetoma remains critically underfunded and neglected despite formal recognition by international health initiatives and the World Health Organization.
  • Reviewed global health declarations, action plans, and milestones concerning neglected tropical diseases (NTDs) from 2012 through 2022.
  • Assessed international research funding priorities, disease reporting policies, and pharmaceutical development pipelines targeting mycetoma.
  • Despite being recognized as an NTD by the World Health Assembly in 2016, mycetoma is excluded from the priority lists of almost all major research funding bodies.
  • The condition remains largely omitted from national public health agendas, lacks mandatory reporting systems in endemic areas, and has zero new drug candidates in the development pipeline.

Cite This Study

Fahal et al. (2022) studied this question.

synapsesocial.com/papers/6a7afdff4c448619ca0e5e07https://doi.org/10.1371/journal.pntd.0010945
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1World NTD Day 2022 and a new Kigali Declaration to galvanise commitment to end neglected tropical diseases2022 · 38 citations
  2. 2Drug Discovery and Development in the Era of Big Data2016 · 19 citations
  3. 3Clinical Features of Mycetoma and the Appropriate Treatment Options2021 · 75 citations